Note 9 Breakdown of gross lending between different stages of IFRS 9
| 30.09.26 | GROUP | |||||
|---|---|---|---|---|---|---|
| Gross lending recognised at amortised cost | Model-based | Total model- based loss | Individually assessed | Total | ||
| Stage 1 | Stage 2 | Stage 3 | Stage 3 | |||
| Gross lending opening balance | 426,861 | 33,513 | 2,096 | 462,470 | 1,138 | 463,608 |
| Transferred to 12-month ECL (Stage 1) | 10,439 | -10,360 | -56 | 23 | -23 | 0 |
| Transferred to lifetime ECL – no objective evidence of loss (Stage 2) | -11,896 | 12,049 | -139 | 14 | -14 | 0 |
| Transferred to lifetime ECL – no objective evidence of loss (Stage 3) – Model-based | -433 | -1,216 | 1,670 | 21 | -21 | 0 |
| Transferred to lifetime ECL – no objective evidence of loss (Stage 3) – Individually assessed | -393 | -307 | -195 | -895 | 895 | 0 |
| Newly issued or acquired financial assets | 136,158 | 8,362 | 394 | 144,914 | 84 | 144,998 |
| Financial assets derecognised – excluding impairment loss | -109,804 | -10,376 | -869 | -121,049 | -229 | -121,278 |
| Net change in existing loans | 5,099 | 736 | 125 | 5,960 | -111 | 5,848 |
| Gross lending closing balance recognised at amortised cost | 456,030 | 32,401 | 3,026 | 491,458 | 1,718 | 493,176 |
| Impairment loss | -383 | -367 | -539 | -1,289 | -685 | -1,974 |
| Net lending at closing balance recognised at amortised cost | 455,647 | 32,034 | 2,487 | 490,169 | 1,033 | 491,202 |
| Lending valued at fair value | 20,041 | |||||
| Capitalised lending closing balance | 511,242 | |||||
| 0 | ||||||
| Gross lending recognised at amortised cost, allocated to different stages closing balance | 456,030 | 32,401 | 3,026 | 491,458 | 1,718 | 493,176 |
| * Of which corporate customers | 129,711 | 21,486 | 2,151 | 153,349 | 1,656 | 155,005 |
| * Of which retail customers | 326,319 | 10,915 | 875 | 338,109 | 62 | 338,171 |
| 30.09.25 | GROUP | |||||
|---|---|---|---|---|---|---|
| Gross lending recognised at amortised cost | Model-based | Total model- based loss | Individually assessed | Total | ||
| Stage 1 | Stage 2 | Stage 3 | Stage 3 | |||
| Gross lending opening balance | 238,884 | 20,333 | 999 | 260,216 | 393 | 260,609 |
| Transferred to 12-month ECL (Stage 1) | 5,305 | -5,225 | -82 | -2 | 2 | 0 |
| Transferred to lifetime ECL – no objective evidence of loss (Stage 2) | -6,488 | 6,702 | -275 | -60 | 60 | 0 |
| Transferred to lifetime ECL – no objective evidence of loss (Stage 3) – Model-based | -210 | -584 | 810 | 16 | -16 | 0 |
| Transferred to lifetime ECL – no objective evidence of loss (Stage 3) – Individually assessed | -119 | -199 | -39 | -357 | 357 | 0 |
| Newly issued or acquired financial assets | 238,576 | 16,300 | 1,160 | 256,036 | 879 | 256,915 |
| Financial assets derecognised – excluding impairment loss | -64,668 | -7,150 | -468 | -72,285 | -405 | -72,690 |
| Net change in existing loans | 3,626 | 1,153 | -9 | 4,769 | -214 | 4,555 |
| Gross lending closing balance recognised at amortised cost | 414,907 | 31,331 | 2,096 | 448,334 | 1,055 | 449,389 |
| Impairment loss | -407 | -558 | -417 | -1,381 | -378 | -1,760 |
| Net lending at closing balance recognised at amortised cost | 414,500 | 30,772 | 1,680 | 446,952 | 677 | 447,629 |
| Lending valued at fair value | 24,827 | |||||
| Capitalised lending closing balance | 472,456 | |||||
| 0 | ||||||
| Gross lending recognised at amortised cost, allocated to different stages closing balance | 414,907 | 31,331 | 2,096 | 448,334 | 1,055 | 449,389 |
| * Of which corporate customers | 118,327 | 18,596 | 1,413 | 138,335 | 1,006 | 139,341 |
| * Of which retail customers | 296,580 | 12,735 | 684 | 309,999 | 49 | 310,048 |

